Epiterna
The business, the turning points, and the decisions behind them.
Some sections are still being researched2 / 4
Sections to complete：02 · 05
01 / WHAT IT BUILT
What the company did
EPITERNA SA was a Swiss longevity biotechnology company founded in 2022 by Alejandro Ocampo and Kevin Perez, based in the Lausanne/Epalinges life-sciences cluster. Its mission was extending healthy lifespan for companion animals and, ultimately, people; its core platform was a high-throughput drug-screening system evaluating how medicines affect aging biology, focused on small-molecule drugs with existing safety data, with initial translational work in dogs.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- Liquidation
Epiterna shareholders resolved to dissolve the company in July 2025 and it entered liquidation.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN / AFTERMATH
Material for this section is being gathered and checked. It will appear here once ready.